Bio-Techne
TECH
#1523
Rank
C$15.76 B
Marketcap
$99.20
Share price
3.39%
Change (1 day)
13.66%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of September 2024 : C$2.98 Billion

According to Bio-Techne's latest financial reports the company has C$2.98 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$C$2.60 B18.9%
2022-06-30$C$2.19 B12.51%
2021-06-30$C$1.94 B3.26%
2020-06-30$C$1.88 B23.29%
2019-06-30$C$1.52 B7.82%
2018-06-30$C$1.41 B15%
2017-06-30$C$1.23 B8.49%
2016-06-30$C$1.13 B8.19%
2015-06-30$C$1.05 B23.94%
2014-06-30$C$0.84 B9.32%
2013-06-30$C$0.77 B12.98%
2012-06-30$C$0.68 B21.11%
2011-06-30$C$0.56 B6.34%
2010-06-30$C$0.53 B0.51%
2009-06-30$C$0.53 B6.84%
2008-06-30$C$0.49 B7.03%
2007-06-30$C$0.46 B22.28%
2006-06-30$C$0.37 B15.65%
2005-06-30$C$0.32 B-17.27%
2004-06-30$C$0.39 B24.42%
2003-06-30$C$0.31 B1.81%
2002-06-30$C$0.31 B16.31%
2001-06-30$C$0.26 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$68.54 B 2,195.79%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.45 B 250.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$36.11 B 1,109.59%๐Ÿ‡บ๐Ÿ‡ธ USA
C$71.62 B 2,298.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.75 B 59.22%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$26.67 B 793.23%๐Ÿ‡บ๐Ÿ‡ธ USA
C$78.33 M-97.38%๐Ÿ‡บ๐Ÿ‡ธ USA